Cancer Comeback upends Tennis Icon

Chris Evert’s latest cancer update is painful for one simple reason: the comeback she fought for keeps being tested.

Story Snapshot

Chris Evert said ovarian cancer has returned after CT and PET scans.
She said she already had surgery and will start chemotherapy soon.
She will step back from work, including Wimbledon, to focus on her health.
Her long public fight has made her one of tennis’s most watched health stories.

The Announcement That Changed Wimbledon Week

Evert shared the news on social media and said she learned the cancer had returned after recent scans^[1]^[2]. She said surgery was the first step in treatment and that chemotherapy will begin in the coming weeks^[1]^[3]. She also said she will step away from professional duties for several months and miss Wimbledon, where she has long been a familiar voice^[1].

The public response was immediate because Evert has never treated her illness as a private side note. She has used every major update to push the same message: know your body, act early, and do not ignore warning signs. That plain-spoken style has helped turn her story from celebrity news into something closer to a public health lesson.

A Cancer Story Built on Early Detection and Recurrence

Evert’s health history gives this update extra weight. ABC News and the Cleveland Clinic said she was first diagnosed in late 2021, after genetic testing showed a BRCA1 mutation linked to higher ovarian cancer risk^[3]^[9]. Those reports also said she later had another cancer episode, which is why this latest return lands with such force^[6]^[9].

That pattern matters because BRCA-related ovarian cancer can be stubborn. Medical research on BRCA1 and BRCA2-associated cancers shows recurrence is a major problem, and recurrent tumors often develop ways to repair treatment damage more effectively^[13]^[14]^[15]. That does not predict one person’s outcome, but it does explain why this disease can come back even after aggressive care.

Why Her Openness Still Resonates

Evert has spent years speaking about the family link behind her diagnosis. ABC News reported that genetic testing tied her risk to the same BRCA1 variant connected to her sister’s cancer^[3]. The Cleveland Clinic story said she learned of the mutation through a genetic counselor and then moved ahead with preventive surgery and treatment^[9].

That is why this latest announcement feels bigger than a sports headline. It also speaks to how high-profile illness gets covered. Outlets tend to lean hard on emotion, because emotion gets clicks. But Evert’s own words stay practical. She talks about scans, surgery, chemotherapy, and time away from work. That simple detail gives the public something more useful than pity.

Tennis Hall of Famer Chris Evert says she will miss Wimbledon after recurrence of ovarian cancer | Story: https://t.co/s5RGjJM6NO pic.twitter.com/SKzhtsvil5

— WHSVnews (@WHSVnews) June 26, 2026

Martina Navratilova, Evert’s longtime rival and friend, publicly sent support after the news, which added another layer of human meaning to the announcement^[2]. In tennis, their rivalry defined an era. In moments like this, it becomes a reminder that the fiercest competitors can still show real loyalty. That part of the story matters because illness strips away the old scoreboard and leaves only the person.

What This Means Going Forward

For now, the key facts are clear. Evert says the cancer has returned, surgery has already happened, and chemotherapy is next^[1]^[3]. She has also said she is stepping back from public duties to focus on treatment^[1]. What the public does not yet have is the exact surgical detail or any outside medical record confirming the scan results, so her statement remains the main source for the latest development.

That is enough to understand the stakes. Evert is not selling drama. She is reporting a hard medical reality in the open, while asking the world to let her heal. For readers, the lesson is blunt and old-fashioned: family history matters, testing matters, and early action can buy time. In cancer, time is often the most valuable thing a person can have.